These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19280679)

  • 1. Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment.
    Dierckx E; Engelborghs S; De Raedt R; Van Buggenhout M; De Deyn PP; Verté D; Ponjaert-Kristoffersen I
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1094-100. PubMed ID: 19280679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
    Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
    Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
    Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety and behavioural disturbance as markers of prodromal Alzheimer's disease in patients with mild cognitive impairment.
    Gallagher D; Coen R; Kilroy D; Belinski K; Bruce I; Coakley D; Walsh B; Cunningham C; Lawlor BA
    Int J Geriatr Psychiatry; 2011 Feb; 26(2):166-72. PubMed ID: 21229599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The California Verbal Learning Test and other standard clinical neuropsychological tests to predict conversion from mild memory impairment to dementia.
    Lekeu F; Magis D; Marique P; Delbeuck X; Bechet S; Guillaume B; Adam S; Petermans J; Moonen G; Salmon E
    J Clin Exp Neuropsychol; 2010 Feb; 32(2):164-73. PubMed ID: 19459119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of the story recall test in patients with mild cognitive impairment and Alzheimer's disease.
    Baek MJ; Kim HJ; Ryu HJ; Lee SH; Han SH; Na HR; Chang Y; Chey JY; Kim S
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2011 Mar; 18(2):214-29. PubMed ID: 21229403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.
    Sarazin M; Berr C; De Rotrou J; Fabrigoule C; Pasquier F; Legrain S; Michel B; Puel M; Volteau M; Touchon J; Verny M; Dubois B
    Neurology; 2007 Nov; 69(19):1859-67. PubMed ID: 17984454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical dementia: an Italian multicentre study on amnestic mild cognitive impairment.
    Perri R; Serra L; Carlesimo GA; Caltagirone C;
    Dement Geriatr Cogn Disord; 2007; 23(5):289-300. PubMed ID: 17356272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning and forgetting new names and objects in MCI and AD.
    Grönholm-Nyman P; Rinne JO; Laine M
    Neuropsychologia; 2010 Mar; 48(4):1079-88. PubMed ID: 20006630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting prodromal Alzheimer's disease in mild cognitive impairment: utility of the CAMCOG and other neuropsychological predictors.
    Gallagher D; Mhaolain AN; Coen R; Walsh C; Kilroy D; Belinski K; Bruce I; Coakley D; Walsh JB; Cunningham C; Lawlor BA
    Int J Geriatr Psychiatry; 2010 Dec; 25(12):1280-7. PubMed ID: 21086538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A delayed recall battery as a sensitive screening for mild cognitive impairment: follow-up study of memory clinic patients after 10 years.
    Takayama Y
    J Med Dent Sci; 2010 Jun; 57(2):177-84. PubMed ID: 21073136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.
    Estévez-González A; Kulisevsky J; Boltes A; Otermín P; García-Sánchez C
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1021-8. PubMed ID: 14618554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The five-word test in three age-groups of mild Alzheimer's disease (60, 70 and 80 year-old patients): Utility of the Total Score, Total Weighted Score, Learning Score and Memory Score].
    Croisile B; Astier JL; Beaumont C; Mollion H
    Rev Neurol (Paris); 2010; 166(8-9):711-20. PubMed ID: 20399477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
    Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
    Fellgiebel A; Kojro E; Müller MJ; Scheurich A; Schmidt LG; Fahrenholz F
    J Geriatr Psychiatry Neurol; 2009 Mar; 22(1):3-9. PubMed ID: 19073834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Language performance in Alzheimer's disease and mild cognitive impairment: a comparative review.
    Taler V; Phillips NA
    J Clin Exp Neuropsychol; 2008 Jul; 30(5):501-56. PubMed ID: 18569251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease.
    Testa JA; Ivnik RJ; Boeve B; Petersen RC; Pankratz VS; Knopman D; Tangalos E; Smith GE
    J Int Neuropsychol Soc; 2004 Jul; 10(4):504-12. PubMed ID: 15327729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study.
    Luckhaus C; Grass-Kapanke B; Blaeser I; Ihl R; Supprian T; Winterer G; Zielasek J; Brinkmeyer J
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1148-55. PubMed ID: 18537220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.